Stevens-Johnson syndrome associated with reduced tear production complicating the use of cetuximab and panitunumab.
Pantano
Francesco
F
Silletta
Marianna
M
Iovieno
Alfonso
A
Vincenzi
Bruno
B
Santini
Daniele
D
Galluzzo
Sara
S
Bonini
Stefano
S
Tonini
Giuseppe
G
D000911:Antibodies, Monoclonal / Q000009:adverse effects* / Q000627:therapeutic use; D061067:Antibodies, Monoclonal, Humanized; D000068818:Cetuximab; D005260:Female; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy / Q000556:secondary; D008875:Middle Aged; D013262:Stevens-Johnson Syndrome / Q000209:etiology*; D013666:Tears / Q000378:metabolism*
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; C545242:panitunumab; D000068818:Cetuximab